Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company provides original glass and smart glass, special glass, low-e coated glass, ultra-high efficiency silicon wafers, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products. In addition, it engages in the supply of oil and gas. The company was formerly known as SichuanHebang Biotechnology Co.,Ltd. and changed its name to Sichuan Hebang Biotechnology Corporation Limited in April 2021. The company was founded in 2002 and is based in Leshan, China.
Research context
Sichuan Hebang Biotechnology Corporation Limited appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Basic Materials
- Industry
- Chemicals
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
SichuanHebang Biotechnology Co.,Ltd is currently in a long term uptrend where the price is trading 24.2% above its 200 day moving average.
From a valuation standpoint, the stock is 27.8% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 2.9.
SichuanHebang Biotechnology Co.,Ltd's total revenue sank by 14.0% to $1B since the same quarter in the previous year.
Its net income has dropped by 245.7% to $-244M since the same quarter in the previous year.
Finally, its free cash flow grew by 117.9% to $40M since the same quarter in the previous year.
Based on the above factors, SichuanHebang Biotechnology Co.,Ltd gets an overall score of 3/5.